|
1
|
Piazza G and Goldhaber SZ: Physician
alerts to prevent venous thromboembolism. J Thromb Thrombolysis.
30:1–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cardiovascular Disease Educational and
Research Trust, ; Cyprus Cardiovascular Disease Educational and
Research Trust, ; European Venous Forum, ; International Surgical
Thrombosis Forum, ; International Union of Angiology, ; Union
Internationale de Phlébologie, . Prevention and treatment of venous
thromboembolism. International Consensus Statement (guidelines
according to scientific evidence). Int Angiol. 25:101–161.
2006.
|
|
3
|
Heit JA: The epidemiology of venous
thromboembolism in the community. Arterioscler Thromb Vasc Biol.
28:370–372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guyatt GH, Akl EA, Crowther M, Gutterman
DD and Schuunemann HJ: American College of Chest Physicians
Antithrombotic Therapy and Prevention of Thrombosis Panel:
Executive summary: Antithrombotic Therapy and Prevention of
Thrombosis, 9th ed: American college of chest physicians
evidence-based clinical practice guidelines. Chest. 141 2
Suppl:7S–47S. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Falanga A and Russo L: Epidemiology, risk
and outcomes of venous thromboembolism in cancer. Hamostaseologie.
32:115–125. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seddighzadeh A, Shetty R and Goldhaber SZ:
Venous thromboembolism in patients with active cancer. Thromb
Haemost. 98:656–661. 2007.PubMed/NCBI
|
|
7
|
Khorana AA, Ahrendt SA, Ryan CK, Francis
CW, Hruban RH, Hu YC, Hostetter G, Harvey J and Taubman MB: Tissue
factor expression, angiogenesis, and thrombosis in pancreatic
cancer. Clin Cancer Res. 13:2870–2875. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kakkar AK: Cancer-associated thrombosis.
Br J Cancer. 102 Suppl 1:S12010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goldhaber SZ and Bounameaux H: Pulmonary
embolism and deep vein thrombosis. Lancet. 379:1835–1846. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang LM, Duan QL, Yi XH, Zeng Y, Gong Z
and Yang F: Venous thromboembolism is a product in proliferation of
cancer cells. Int J Clin Exp Med. 7:1319–1323. 2014.PubMed/NCBI
|
|
11
|
Wang LM, Duan QL, Yang F, Yi XH, Zeng Y,
Tian HY, Lv W and Jin Y: Activation of circulated immune cells and
inflammatory immune adherence are involved in the whole process of
acute venous thrombosis. Int J Clin Exp Med. 7:566–572.
2014.PubMed/NCBI
|
|
12
|
Wang L, Gong Z, Jiang J, Xu W, Duan Q, Liu
J and Qin C: Confusion of wide thrombolytic time window for acute
pulmonary embolism: Mass spectrographic analysis for thrombus
proteins. Am J Respir Crit Care Med. 184:145–146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giancotti FG and Ruoslahti E: Integrin
signaling. Science. 285:1028–1032. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Humphries MJ: Integrin structure. Biochem
Soc Trans. 28:311–339. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takada Y, Ye X and Simon S: The integrins.
Genome Biol. 8:2152007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiong JP, Stehle T, Diefenbach B, Zhang R,
Dunker R, Scott DL, Joachimiak A, Goodman SL and Arnaout MA:
Crystal structure of the extracellular segment of integrin alpha
Vbeta3. Science. 294:339–345. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gerber DJ, Pereira P, Huang SY, Pelletier
C and Tonegawa S: Expression of alpha v and beta 3 integrin chains
on murine lymphocytes. Proc Natl Acad Sci USA. 93:pp. 14698–14703.
1996; View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lityńska A, Przybyło M, Ksiazek D and
Laidler P: Differences of alpha3beta1 integrin glycans from
different human bladder cell lines. Acta Biochim Pol. 47:427–434.
2000.PubMed/NCBI
|
|
19
|
Solovjov DA, Pluskota E and Plow EF:
Distinct roles for the alpha and beta subunits in the functions of
integrin alphaMbeta2. J Biol Chem. 280:1336–1345. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song Y, Yang F, Wang L, Duan Q, Jin Y and
Gong Z: Increased expressions of integrin subunit β1, β2 and β3 in
patients with venous thromboembolism: New markers for venous
thromboembolism. Int J Clin Exp Med. 7:2578–2584. 2014.PubMed/NCBI
|
|
21
|
Shaboodien R, Stansby G, Hunt BJ and
Agarwal R: Unprovoked venous thromboembolism: Assess for cancer.
Lancet Oncol. 13:973–974. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song Y, Wang L, Yang F, Li G, Duan Q and
Gong Z: Increased expressions of integrin subunit β1, β2 and β3 in
patients with cancer-correlation analysis between risk factors of
VTE and expression of core proteins. Int J Clin Exp Med.
8:2772–2777. 2015.PubMed/NCBI
|
|
23
|
Chong LY, Fenu E, Stansby G and Hodgkinson
S; Guideline Development Group, : Management of venous
thromboembolic diseases and the role of thrombophilia testing:
Summary of NICE guidance. BMJ. 344:e39792012. View Article : Google Scholar : PubMed/NCBI
|
